Author: healthylife7

At IFT FIRST 2026 in Chicago, US (Jul 12–15), Foodology by Univar Solutions is positioning its booth as a showcase for several active formulation priorities. These include GLP-1-aligned product development, clean label reformulation, protein fortification, and plant-based alternatives

US Senator Lindsey Graham died of an “aortic dissection” caused by cardiovascular disease, according to a preliminary finding by the Washington DC medical examiner

Does your risk of fatty liver go up after gallbladder surgery? Top gastro explains | Health and Wellness News – The Indian Express skip to content

Some days, happiness feels elusive. Perhaps it’s the endless grey skies of the monsoon, when the lack of sunshine and constant rain leave many people feeling sluggish. Or maybe it’s the daily grind, a difficult boss, financial worries, relationship troubles or simply an endless to-do list, that makes even the smallest joys seem distant

Air pollution is an established risk factor for cardiovascular and metabolic diseases, but evidence on chronic kidney diseases (CKD) remains limited

A pharmacist has warned that patients interested in the new Wegovy pill may not be getting the full picture on the strict rules, side effects, and safety risks linked to the once-daily tablet. The tablet, which contains semaglutide, has been approved in the UK for weight loss and weight management, creating a new oral form…

Ah, the pull-up. For many outdoor athletes, this classic bodyweight exercise can feel like a “gold standard,” says Jess Gresho, a Colorado-based strength and performance coach for mountain athletes. “They always want to get their first pull-up, and think it’s a benchmark of some sort that puts them at a different level.”

Alongside the growth of health and wellness in the food industry, the idea of personalised nutrition for each individual has also gained a great deal of traction, though this has been severely limited by both technology and cost challenges

‘There is no evidence that implementing woke medicine improves health outcomes,’ researcher says

D&D Pharmatech (347850.KQ) has expanded its joint research collaboration with U.S. pharmaceutical company Pfizer on an obesity treatment. Following an additional order from Pfizer, the value of the research service contract has increased 38% from the previous level, and the contract term has been extended until 2028